| Title： | Experts consensus on the clinical application of liver contrast-enhanced US with Sonazoid in China |
| Edition： | Original |
| Classification： | Experts consensus |
| Field： | Comprehensive guideline |
| Countries and regions： | China |
| Guidelines users： | Sonographers and clinicians involved in the clinical care of liver diseases from medical institutions at all levels |
| Evidence classification method： | Grading of Recommendations Assessment, Development and Evaluation (GRADE) |
| Development unit： | Chinese Society of Ultrasound in Medicine |
| Registration time: | 2024-04-02 |
| Registration number： | PREPARE-2024CN484 |
| Purpose of the guideline: | Sonazoid is a Kupffer-cell specific contrast agent. Contrast-enhanced US with Sonazoid plays a very important role in the screening, diagnosis, intraoperative and interventional procedures, and efficacy assessment of liver diseases. We aimed to standardize the use of contrast-enhanced US with Sonazoid in the management of liver disease in the experts consensus. |
